Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
10.3802/jgo.2019.30.e116
Author:
Rongyu ZANG
1
;
Jianqing ZHU
Author Information
1. Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Fudan University Zhongshan Hospital, Shanghai, China. zang.rongyu@zs-hospital.sh.cn
Publication Type:Editorial
MeSH:
Humans;
Ovarian Neoplasms
From:Journal of Gynecologic Oncology
2019;30(6):e116-